Decitabine–cedazuridine

Status:

Do Not Prescribe (DNP)

Decision Date:

December 2023

Comments

DNP: NICE TA932 Decitabine–cedazuridine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable. Terminated appraisal (Decision - December 2023)

search again